semaglutide comes from New obesity drug is safe and effective for weight loss and diabetes Spotlight on the Mechanism of
Description
They also contain the same active ingredient, semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist
Patient aversions to injectable therapies in type 2 diabetes are well documented
They require special attention in clinical weight management and early prevention and treatment of metabolic syndrome [i] , whereas the effective drug treatment options are limited
& Shi, Z
To find UK clinical trials, patients and clinicians can use NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) or the ISRCTN registry (isrctn.com)
Vector Laboratories) for 30 min
